This report describes the extent of inclusion of nurses in pharmaceutical company-sponsored educational events in Australia.
This historical analysis uses internal sugar industry documents to describe how the industry sought to influence the scientific debate over the dietary causes of coronary heart disease in the 1950s and 1960s.
This study examines the association between employees of the cardiovascular device industry who served as coauthors of articles reporting clinical trials of the industry’s products and the outcomes of those trials.
This study reviewed transcripts of meetings of the Oncologic Drugs Advisory Committee to the US Food and Drug Administration to characterize potential financial and other conflicts of interest of public speakers.
This Viewpoint emphasizes that nutrition researchers and professional societies need to recognize the influence of food-industry sponsorship, take steps to control its effects, and ensure that sponsored studies promote public health.
This survey study examined the nature, extent, and perceived consequences of industry relationships among institutional review board members in academic health centers and compared the results with findings from 2005.
This database review assesses the disclosure to study participants of boxed warning risks on consent forms.
Neltner et al determine the extent to which individuals selected by manufacturers to make “generally recognized as safe” determinations have conflicts of interest between their obligations to ensure that the use of the additive is safe and their financial relationships to the company. Nestle provides an Invited Commentary on the topic.
Braun describes how low testosterone level has been marketed to consumers as a disease state in order to boost sales of testosterone replacement therapies.